近日,来自澳门科技大学的研究者们在Signal Transduction and Targeted Therapy杂志上发表了题为“STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway”的文章,该研究证实了STAT3-NAV2轴通过激活SSH1L/cofilin-1信号通路成为类风湿关节炎治疗的新靶点。
Ran Wang et al. STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway. Signal Transduct Target Ther. 2022 Jul 8;7(1):209. doi: 10.1038/s41392-022-01050-7.